How many total In Vitro Diagnostics companies are there?

As of Apr 2026, there are 2,921 active companies in In Vitro Diagnostics sector.

Which countries have the most In Vitro Diagnostics companies?

United States (1,642) has the highest number of In Vitro Diagnostics companies, followed by United Kingdom (263) and India (177).

How many In Vitro Diagnostics companies are funded?

As of Apr 2026, 2,143 companies in this sector have received funding.

Which company has raised the most funding in In Vitro Diagnostics sector?

As of Apr 2026, Freenome Health has secured $1.35B in funding, making it the highest-funded company in the In Vitro Diagnostics sector.

Which country has attracted the most investment in In Vitro Diagnostics companies?

With $20.4B in total funding, United States has attracted the most investment among In Vitro Diagnostics companies.

Who are the top investors in In Vitro Diagnostics companies?

The top investors in In Vitro Diagnostics companies by number of investments are HHS, Europa and EIC Fund

How much venture capital has In Vitro Diagnostics sector attracted?

In the last 10 years, venture capital firms have invested $14B in this sector.

How many unicorns has In Vitro Diagnostics sector produced?

Globally, there are 6 unicorns in In Vitro Diagnostics sector, to date.

In Vitro Diagnostics - 2026 Market & Investments Trends

Companies included in In Vitro Diagnostics sector

Companies developing assays on samples such as blood or tissue that have been taken from the human body for the diagnosis of various diseases.

Companies excluded in In Vitro Diagnostics sector

Traditional Diagnostic Technologies, Diagnostic Devices, In vivo Testing Technologies

Key Metrics

Total Companies

3.68K

Top Companies

Guardant Health, Natera & more

Total Funding

Funded Companies

Series A+ Companies

Series C+ Companies

Unicorns Created

IPOs

178

Acquisitions

338

View complete details of this sector

The market map of In Vitro Diagnostics gives a visual overview of the sector, showing key business models, their interactions in the value chain, and industry evolution. Top 3 trending business models in In Vitro Diagnostics sector are Neurological Diagnostics, Pan Cancer Analysis Tests and Veterinary In Vitro Diagnostics.

Recent BlueBox/Industry Definition image of In Vitro Diagnostics

Here are some reports related to In Vitro Diagnostics sector:

Free

In Vitro Diagnostics - Sector Report

Edition: November, 2025 (78 Pages)

Premium

In Vitro Diagnostics Investor Landscape

Edition: March, 2025 (12 Pages)

View all reports related to In Vitro Diagnostics. Sign up today!

There are more than 3.68K companies in In Vitro Diagnostics. Guardant Health is the top In Vitro Diagnostics company globally, ranked using Tracxn Score (what's this?).

Here are 5 of the top In Vitro Diagnostics companies globally:

Company	Description	Location	Founded	Current Stage	Private Funding Raised
Guardant Health	Developer of digital sequencing technology for cancer detection	Redwood City (United States)	2012	Public	$557M
Natera	Developer of cell-free DNA testing for oncology, women’s health, and organ health	Redwood City (United States)	2004	Public	$152M
Myriad Genetics	Developer of molecular diagnostics and personalized medicine for cancer	United States	1991	Public	-
Biodesix	Developer of diagnostics assays for the detection of cancer	Boulder (United States)	2005	Public	$200M
Cepheid	Developer of molecular diagnostic testing solutions	Sunnyvale (United States)	1996	Acquired	$19.1M

Get a longer list of companies

Companies founded year-on-year in the In Vitro Diagnostics sector

1 new startup has been founded so far in 2026 in the In Vitro Diagnostics sector. 210 In Vitro Diagnostics startups were founded in 2017 - this is the most number of startups founded in any year in the last 10 years.

Total Number of Companies

Year	No. of companies
2026	1
2025	9
2024	31
2023	51
2022	67
2021	103
2020	166
2019	140
2018	180
2017	210

Companies founded across countries in the In Vitro Diagnostics sector

United States has 1,642 In Vitro Diagnostics startups, the most by any country, followed by United Kingdom which has 263 startups and India which has 177.

Total Number of Companies

Country	No. of companies
United States	1,642
United Kingdom	263
India	177
Germany	166
China	164
Canada	123
Israel	117
Sweden	93
South Korea	90
France	90

Stage-wise distribution of the In Vitro Diagnostics sector

Out of the total 3,678 In Vitro Diagnostics companies, 2,143 have secured funding. Among them, 941 have reached Series A or higher, and 711 to Series B or beyond.

Founded - 3,678

Funded - 2,143

Series A+ - 941

Series B+ - 711

Series C+ - 611

Company Stage	No. of companies
Founded	3,678
Funded	2,143
Series A+	941
Series B+	711
Series C+	611

Want to know more about In Vitro Diagnostics ? Signup and explore Tracxn for free

3.7K+ Total Companies
$43.7B+ Total Funding
2.1K+ Funded Companies
175+ IPOs
335+ Acquisitions

Total funding year-on-year in the In Vitro Diagnostics sector

The In Vitro Diagnostics sector saw a total funding of more than $29B in the last 10 years. The most amount of funding was in 2021 at more than $5.32B. There has been a total funding of $240M in 2026 till date.

Total Funding

Year	Total Funding
2026	$240M
2025	$2.13B
2024	$1.73B
2023	$1.21B
2022	$2.37B
2021	$5.32B
2020	$5.17B
2019	$3.69B
2018	$3.75B
2017	$3.43B

Total funding across countries in the In Vitro Diagnostics sector

In the last 10 years, In Vitro Diagnostics startups in United States have recieved the highest funding among all countries - $20.4B. China follows with $2.46B and United Kingdom with $785M.

Total Funding

Country	Total Funding
United States	$20.4B
China	$2.46B
United Kingdom	$785M
Israel	$448M
Spain	$381M
Sweden	$211M
India	$210M
Germany	$205M
France	$201M
Switzerland	$175M

Total funding amount raised by stage in the In Vitro Diagnostics sector

Over the last 10 years, the In Vitro Diagnostics sector have seen $655M into Seed Stage funding rounds, $8.61B into Early Stage funding rounds and $9.18B go into Late Stage funding rounds.

Funding Stage	Total Funding
Late Stage	$9.18B
Early Stage	$8.61B
Post IPO	$6.47B
Grant	$1.49B
Debt	$789M
Seed Stage	$655M
PE	$139M
Other-Equity	$800K

Recent Funding Rounds in In Vitro Diagnostics

In the year 2026, till March 2026, In Vitro Diagnostics companies have raised $177M in equity funding across 13 rounds. In the same period last year (i.e. till March 2025), In Vitro Diagnostics companies had raised $211M across 19 rounds. So, 2026 has seen a 16.16% drop in funding in In Vitro Diagnostics companies as compared to 2025.

Here are some recent, important funding rounds in In Vitro Diagnostics:

Company	Round Raised	Amount Raised	Funding Date	Investors
AIQ Solutions	Series A	5109	Mar 20, 2026	-
Sequential Bio	Series A	3805	Mar 17, 2026	Sparkfood and 4 more
Diamens	Seed	3666	Mar 17, 2026	EQventure and 3 more
Jana Care	Series C	3919	Mar 12, 2026	-
Waiv	Series C	6197	Mar 12, 2026	OTB Ventures and 4 more

See a more detailed list of funding rounds

HHS is the top investor in In Vitro Diagnostics companies based on number of companies invested.

Here are some top investors in In Vitro Diagnostics:

Investor	Location	Top Portfolio Companies
HHS	Washington, DC (United States)	Natera, Myriad Genetics, Cepheid and Adaptive Biotechnologies
Europa	Belgium	Caris Life Sciences, MeMed, UDX and OpGen
EIC Fund	Brussels (Belgium)	MeMed, UDX, Vitestro and Dxcover
National Science Foundation	Arlington (United States)	Prometheus Laboratories, Amplified Sciences, Proov and Akonni
NIH	United States	Cepheid, Inflammatix, Day Zero Diagnostics and CND Life Sciences

See a more detailed list of investors

In the year 2026, till March 2026, 6 acquisitions happened in In Vitro Diagnostics sector. Last year, in 2025, a total of 11 acquisitions happened in In Vitro Diagnostics sector.

Here are some recent, important acquisitions in In Vitro Diagnostics:

Company	Acquisition Type	Acquisition Date	Acquirers
Exact Sciences	Business Acquisition	Mar 20, 2026	Abbott
Ignite Proteomics	Business Acquisition	Mar 13, 2026	Aditx Therapeutics
Xebios	Business Acquisition	Mar 06, 2026	Solabia
InDevR	Business Acquisition	Feb 06, 2026	-
OnCompass Medicine	Business Acquisition	Jan 14, 2026	Genomate Health

See a more detailed list of acquisitions

Acquisition trends in In Vitro Diagnostics

Here are the acquisition trends in In Vitro Diagnostics:

Total Number of Acquisitions

Year	No. of companies
2026	6
2025	11
2024	11
2023	17
2022	24
2021	32
2020	23
2019	20
2018	23
2017	25

In the year 2026, till February 2026, 2 IPOs happened in In Vitro Diagnostics sector.

Here are some recent, important IPOs in In Vitro Diagnostics:

Company	IPO Date	Exchange Symbol
BioLab	Feb 19, 2026	National Association of Securities Dealers Automated Quotations (NASDAQ)
Souzhou Ribo Life Science	Jan 09, 2026	Hong Kong Exchanges (HKG)
Prolight Diagnostics	Dec 11, 2025	London Stock Exchange (LSE)
BillionToOne	Nov 06, 2025	National Association of Securities Dealers Automated Quotations (NASDAQ)
NEXSEN BioTech	Oct 14, 2025	Australian Securities Exchange (ASX)

See a more detailed list of IPOs

Companies founded by alumni from top colleges in the In Vitro Diagnostics sector

Most number of In Vitro Diagnostics startups have been founded by alumni from Stanford University, Harvard University and Massachusetts Institute of Technology.

College	No. of companies
Stanford University	57
Harvard University	52
Massachusetts Institute of Technology	51
University of Cambridge	30
University of Oxford	30
Tel Aviv University	29
Harvard Business School	28
Cornell University	26
University of Pennsylvania	23
University of California (Berkeley)	20

Total funding in companies founded by alumni from top colleges in the the In Vitro Diagnostics sector

In the last 10 years, Stanford University graduates' In Vitro Diagnostics companies have raised the most funding among top colleges. University of Oxford alumni are second, and Cornell University alumni are third.

College	Total Funding
Stanford University	$3.95B
University of Oxford	$2.25B
Cornell University	$2.19B
Harvard Business School	$1.85B
Harvard University	$1.72B
Massachusetts Institute of Technology	$1.68B
University College London	$1.36B
University of Cambridge	$861M
Duke University	$734M
University of Chicago	$671M